| MILD | IM-HLH or IM-CAEBV | P-value |
---|---|---|---|
(n = 31) | (n = 7) |  | |
Gender | >o.o5 | ||
 male | 18(58.1%) | 3(42.9%) |  |
 female | 13(41.9%) | 4(57.1%) |  |
Age | >o.o5 | ||
 0–14 | 24(77.4%) | 5(71.4%) |  |
 >14 | 7(22.6%) | 2(28.6%) |  |
Leukocyte count | >o.o5 | ||
 4 × 109/L | 7(22.6%) | 2(28.6%) |  |
 4–10 × 109/L | 8(25.8%) | 1(14.3%) |  |
 ≥10 × 109/L | 16(51.6%) | 4(57.1%) |  |
 Median(range) | 10.85(1.2–43.0) | 14.9(1.5–61.0) |  |
ALT or AST | >o.o5 | ||
 high | 27(87.1%) | 7(100%) |  |
 normal/low | 4(12.9%) | 0(0%) |  |
coagulopathy | >o.o5 | ||
 positive | 22(74.2%) | 6(85.7%) |  |
 negative | 9(25.8%) | 1(14.3%) |  |
ferritin high | >o.o5 | ||
 high | 24(77.4%) | 6(85.7%) |  |
 normal/low | 7(22.6%) | 1(14.3%) |  |
Triglyceride | >0.05 | ||
 high | 24(77.4%) | 6(85.7%) |  |
 normal/low | 7(22.6%) | 1(14.3%) |  |
hepatosplenomegaly | >o.o5 | ||
 yes | 22(71.0%) | 6(85.7%) |  |
 no | 9(29.0%) | 1(14.3%) |  |
lymphoadenopathy | Â | Â | >o.o5 |
 yes | 24(77.4%) | 5(71.4%) |  |
 no | 7(22.6%) | 2(28.6%) |  |
Days after onset of disease | <o.o5 | ||
 average time | 34.8d | 119.7d(4/7, 3 decreased) |  |